{"id":"W4281722441","doi":"10.1007/s11523-022-00884-z","title":"A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study","year":2022,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Boehringer Ingelheim","keywords":"Medicine; Afatinib; Internal medicine; Oncology; Response Evaluation Criteria in Solid Tumors; Neratinib; Cancer; Epidermal growth factor receptor; Breast cancer; Clinical trial; Erlotinib; Phases of clinical research; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001264784,0.001998823,0.002568887,0.0003875295,0.0004541204,0.001369371,0.0007717924,0.001695233,0.00498678],"category_scores_gemma":[0.001160012,0.0004913054,0.002062435,0.0005177255,0.0008146584,0.001530319,0.0005518369,0.003559579,0.001125587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00106326,"about_ca_system_score_gemma":0.001302072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001162584,"about_ca_topic_score_gemma":0.003764124,"domain_scores_codex":[0.9996411,0.0001265681,0.00001679827,0.00007114495,0.00003029701,0.0001140886],"domain_scores_gemma":[0.9994307,0.00009215496,0.0000985929,0.00004626071,0.00003706455,0.0002951826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8093213,0.01144181,0.00713887,0.001061236,0.004311147,0.0006521191,0.0003297267,0.00516824,0.02885765,0.001559971,0.01634507,0.1138129],"study_design_scores_gemma":[0.8844901,0.09604952,0.00793211,0.0000491217,0.0008985724,0.0006580796,0.0001192208,0.001498232,0.001749624,0.001389327,0.005086343,0.00007971885],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859722,0.003088205,0.0007900615,0.002469093,0.0003508948,0.001015701,0.002766036,0.0001621748,0.003385646],"genre_scores_gemma":[0.9852399,0.00261724,0.001512653,0.002054294,0.0001715953,0.001187861,0.003737564,0.0000763268,0.003402606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00498678,"threshold_uncertainty_score":0.01668251,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06037269198487216,"score_gpt":0.3976504848924063,"score_spread":0.3372777929075341,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}